Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$14.9M
1 round on record
Latest round
$14.9M
Venture round · Oct 2026 · this month
Backers
1
Kurma Partners
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 20 Raised a round Venture round $14.9M · Pulse 2.0
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2026 $14.9M — Pulse 2.0
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

MedinCell creates better medicine for all through innovative long‑acting therapies that help improve global health.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Kurma PartnersVia a fund
62 portfolio companies: Xeltis, Zealand Pharma, Agencek2 and 59 more

News

News Pulse 2.0 12 days ago
Medincell Secures €13.8 Million In Non-Dilutive Financing
Medincell has secured an additional €13.8 million in non-dilutive financing from European commercial banks and Bpifrance, bringing the biopharmaceutical company's total non-dilutive financing secured since July 2026 to €41.8 million. The post Medincell Se
Read more
Report

Financials

Total raised
$14.9M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $14.9M Details